Exhibit 107

Calculation of Filing Fee Table

Form S-1

(Form Type)

Benitec Biopharma Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

     Security
Type		   Security Class Title   Fee
Calculation
or Carry
Forward
Rule		   Amount
Registered		   Proposed
Maximum
Offering
Price Per
Unit		  

Proposed

Maximum
Aggregate
Offering Price(1)

   Fee Rate   Amount of
Registration
Fee

Fees to Be Paid

   Equity  

Shares of common stock, par value $0.0001 per share(2)(3)

   457(o)   —   —   $23,000,000.00   0.0000927   $2,132.10

Fees to Be Paid

   Equity  

Common Warrants

   457(g)   —   —   —   —   (4)

Fees to Be Paid

   Equity  

Pre-Funded Warrants(3)

   457(g)   —   —   —   —   (4)

Fees to Be Paid

   Equity  

Shares of common stock, par value $0.0001 per share(2)(5)

   457(o)   —   —   $23,000,000.00   0.0000927   $2,132.10

Fees to Be Paid

   Equity  

Shares of common stock, par value $0.0001 per share(2)(3)(6)

   457(o)   —   —   (3)   0.0000927   (3)
     Total Offering Amounts        $46,000,000.00        $4,264.20
     Total Fees Previously Paid                  —
     Total Fee Offsets                  —
     Net Fee Due                  $4,264.20

 

(1)

Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

 

(2)

Pursuant to Rule 416(a) under the Securities Act, there is also being registered hereby an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions.

 

(3)

The proposed maximum aggregate offering price of the common stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the pre-funded warrants offered and sold in the offering (plus the aggregate exercise price of the common stock issuable upon exercise of the pre-funded warrants), and as such the proposed aggregate maximum offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $23,000,000.00 (including the underwriter’s option to purchase additional shares of common stock).

 

(4)

No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.

 

(5)

Shares of common stock issuable upon exercise of the Common Warrants.

 

(6)

Shares of common stock issuable upon exercise of the Pre-Funded Warrants.